Quarterly report pursuant to Section 13 or 15(d)

REVENUES FROM CONTRACTS WITH CUSTOMERS - Disaggregation of net revenues (Details)

v3.23.3
REVENUES FROM CONTRACTS WITH CUSTOMERS - Disaggregation of net revenues (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues $ 15,279 $ 16,043 $ 44,405 $ 55,074
Qbrexza        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 5,865 6,265 18,038 19,752
Accutane        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 4,882 4,121 15,109 14,228
Amzeeq        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 2,336 1,161 4,904 5,892
Zilxi        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 681 554 1,567 1,851
Targadox        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 929 1,168 2,386 6,558
Exelderm        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 764 1,001 1,813 3,018
Ximino        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues (199) $ 1,773 567 $ 3,775
Luxamend        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues $ 21   $ 21